KILITCH DRUGS (INDIA) Financial Statement Analysis
|
||
The Revenues of KILITCH DRUGS (INDIA) have increased by 66.71% YoY .
The Earnings Per Share (EPS) of KILITCH DRUGS (INDIA) has increased by 41.86 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
KILITCH DRUGS (INDIA) Last 5 Annual Financial Results
[BOM: 524500|NSE : KILITCH]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹114 Cr | ₹69 Cr | ₹53 Cr | ₹82 Cr | ₹51 Cr |
Expenses | ₹104 Cr | ₹63 Cr | ₹53 Cr | ₹76 Cr | ₹46 Cr |
Operating Profit (Excl OI) | ₹11 Cr | ₹5.32 Cr | ₹-0.01 Cr | ₹6.02 Cr | ₹5.30 Cr |
Other Income | ₹2.91 Cr | ₹2.67 Cr | ₹4.55 Cr | ₹5.27 Cr | ₹3.27 Cr |
Interest | ₹1.33 Cr | ₹0.88 Cr | ₹0.94 Cr | ₹0.65 Cr | ₹0.42 Cr |
Depreciation | ₹2.47 Cr | ₹1.99 Cr | ₹2.00 Cr | ₹2.05 Cr | ₹2.04 Cr |
Profit Before Tax | ₹9.61 Cr | ₹5.12 Cr | ₹1.61 Cr | ₹8.59 Cr | ₹6.11 Cr |
Profit After Tax | ₹6.21 Cr | ₹3.77 Cr | ₹0.84 Cr | ₹3.83 Cr | ₹5.15 Cr |
Consolidated Net Profit | ₹7.37 Cr | ₹3.67 Cr | ₹0.84 Cr | ₹3.83 Cr | ₹5.15 Cr |
Earnings Per Share (Rs) | ₹6.71 | ₹4.73 | ₹2.37 | ₹0.55 | ₹2.49 |
PAT Margin (%) | 5.93 | 5.44 | 5.48 | 1.58 | 4.64 |
ROE(%) | 5.86 | 4.73 | 3.09 | 0.71 | 3.36 |
ROCE(%) | 10.26 | 7.26 | 4.40 | 1.95 | 7.59 |
Total Debt/Equity(x) | 0.15 | 0.15 | 0.12 | 0.11 | 0.08 |
Key Financials |
||
Market Cap | : | ₹ 572.6 Cr |
Revenue (TTM) | : | ₹ 155.0 Cr |
Net Profit(TTM) | : | ₹ 12.8 Cr |
EPS (TTM) | : | ₹ 7.9 |
P/E (TTM) | : | 44.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
KILITCH DRUGS (INDIA) | 1.3% | -8.8% | 105.7% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -6.3% | 53.5% |
CIPLA | 1% | -5% | 53.3% |
DR REDDYS LABORATORIES | 1.1% | 2.2% | 26% |
ZYDUS LIFESCIENCES | 3.9% | -1.7% | 85.2% |
DIVIS LABORATORIES | 3.2% | 15.3% | 23.6% |
MANKIND PHARMA | -2.7% | 1.6% | NA |
TORRENT PHARMACEUTICALS | -0.7% | 2.8% | 61.9% |
LUPIN | 3.3% | 1.9% | 137.2% |
KILITCH DRUGS (INDIA) Revenues
[BOM: 524500|NSE : KILITCH]
Y-o-Y | 66.71 % |
5 Yr CAGR | 22.33 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹114 Cr | 66.71 | |
Mar2022 | ₹69 Cr | 28.51 | |
Mar2021 | ₹53 Cr | -35.36 | |
Mar2020 | ₹82 Cr | 61.71 | |
Mar2019 | ₹51 Cr | - |
KILITCH DRUGS (INDIA) Operating Profit
[BOM: 524500|NSE : KILITCH]
Y-o-Y | 97.59 % |
5 Yr CAGR | 18.65 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹11 Cr | 97.59 | |
Mar2022 | ₹5.32 Cr | Positive | |
Mar2021 | ₹-0.01 Cr | Negative | |
Mar2020 | ₹6.02 Cr | 13.63 | |
Mar2019 | ₹5.30 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 18.43 % |
5 Yr CAGR | -3.02 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 9.19% | 18.43 | |
Mar2022 | 7.76% | Positive | |
Mar2021 | -0.02% | Negative | |
Mar2020 | 7.3% | -29.74 | |
Mar2019 | 10.39% | - |
KILITCH DRUGS (INDIA) Profit After Tax
[BOM: 524500|NSE : KILITCH]
Y-o-Y | 100.68 % |
5 Yr CAGR | 9.35 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹7.37 Cr | 100.68 | |
Mar2022 | ₹3.67 Cr | 335.99 | |
Mar2021 | ₹0.84 Cr | -78.02 | |
Mar2020 | ₹3.83 Cr | -25.67 | |
Mar2019 | ₹5.15 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 9.01 % |
5 Yr CAGR | 6.32 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 5.93 % | 9.01 | |
Mar2022 | 5.44 % | -0.73 | |
Mar2021 | 5.48 % | 246.84 | |
Mar2020 | 1.58 % | -65.95 | |
Mar2019 | 4.64 % | - |
KILITCH DRUGS (INDIA) Earnings Per Share (EPS)
[BOM: 524500|NSE : KILITCH]
Y-o-Y | 41.86 % |
5 Yr CAGR | 28.12 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹6.71 | 41.86 | |
Mar2022 | ₹4.73 | 99.58 | |
Mar2021 | ₹2.37 | 330.91 | |
Mar2020 | ₹0.55 | -77.91 | |
Mar2019 | ₹2.49 | - |
KILITCH DRUGS (INDIA) Return on Capital Employed (ROCE)
[BOM: 524500|NSE : KILITCH]
Y-o-Y | 41.32 % |
5 Yr CAGR | 7.83 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 10.26% | 41.32 | |
Mar2022 | 7.26% | 65.00 | |
Mar2021 | 4.4% | 125.64 | |
Mar2020 | 1.95% | -74.31 | |
Mar2019 | 7.59% | - |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Current Share Price | : | ₹355.7 |
Current MarketCap | : | ₹ 572.6 Cr |
Updated EOD on | : | May 02,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 1.3% |
-8.8% |
105.7% |
SENSEX | 1% |
2.2% |
23.7% |
KILITCH DRUGS (INDIA) related INDICES
You may also like the below Video Courses
FAQ about KILITCH DRUGS (INDIA) Financials
How the annual revenues of KILITCH DRUGS (INDIA) have changed ?
The Revenues of KILITCH DRUGS (INDIA) have increased by 66.71% YoY .
How the Earnings per Share (EPS) of KILITCH DRUGS (INDIA) have changed?
The Earnings Per Share (EPS) of KILITCH DRUGS (INDIA) has increased by 41.86 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs